The cell line authentication and characterization tests market is expected to expand at a CAGR of 8.4% from 2022 to 2030.
The cell line authentication and characterization tests market is expected to expand at a CAGR of 8.4% from 2022 to 2030.
COVID-19 Impact
Cell lines have been gaining increased attention for vaccine production, antibody production, and synthesis of biological compounds, among other applications during the ongoing COVID-19 pandemic. Such trends have been translating into revenue opportunities for companies in the cell line authentication and characterization tests market. This is evident since India completed administering one billion vaccine doses, and the region’s coronavirus cases have dropped significantly as compared to Russia and the U.K. where fresh infection cases are being registered.
Download Sample @ https://qyresearchmedical.com/sample/111500
Applied Biological Materials Inc. (abm) – a Canadian company that is constantly on the lookout for the latest innovations in life sciences research, is offering a unique collection of stable cell lines related to the coronavirus basic biology.
Additional Isolation Methods Help Ensure Culture Purity in Vision Research
The field of vision research is not exempt from the woes of misidentified cell lines. The human eye is a complex organ structure where specialized niches of cells reside. The choriocapillaris endothelium and retinal pigment epithelium are two examples of cell types that are frequently isolated for the study of blind eye diseases of the posterior pole of the eye, such as diabetic retinopathy, age-related macular degeneration, proliferative vitreoretinopathy, and the likes. The challenge of culturing these specialized cell types can be exacerbated by cell heterogeneity.
In order to ensure culture purity, laboratories are expected to consider implementing additional isolation methods such as magnetic-activated cell sorting (MACS) or fluorescence-activated cell sorting (FACS).
STR Profiling Emerging as Widely Used Method for Cell Line Authentication
The cell line authentication and characterization tests market is projected to surpass US$ 753 Mn by 2031. Cell lines are fundamental research tools that serve as models for complex biological systems, especially those of human tissue. Thus, to enable meaningful tissue-specific conclusions in cell-based experiments and ensure reproducibility, it is imperative that cell lines accurately represent the cellular identities of its original source or donor.
Stakeholders in the cell line authentication and characterization tests market are unlocking revenue opportunities with a widely used method for cell line authentication, which involves STR (Short Tandem Repeat) profiling.
Custom Cell Authentication Services Ensure Valid and Reproducible Results
The cell line authentication and characterization tests market is expected to expand at a CAGR of 8.4% from 2021 to 2031. Custom cell authentication services are growing prominent in the cell line authentication and characterization tests market. ATCC or the American Type Culture Collection – a nonprofit organization which collects, stores, and distributes standard reference microorganisms, cell lines, and other materials for research & development, is gaining recognition for its custom cell authentication services.
The cell line authentication and characterization tests market is undergoing a significant change with standardized techniques for authentication that ensure valid and reproducible results. A range of services to authenticate and characterize the cells includes viability, sterility, and mycoplasma, among others.
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/111500/2900
ISO Standards Enable Routine Testing of Cell Cultures to Prevent Misidentification
Verifying the identity and purity of human cell lines is essential to the integrity of research activities. Companies in the cell line authentication and characterization tests market are increasing R&D in human cell authentication assays that identify short term repeat (STR) markers. Stakeholders in the cell line authentication and characterization tests market are making use of multiplex polymerase chain reaction (PCR) to simultaneously amplify the amelogenin gene and some of the most informative polymorphic markers in the human genome.
Companies in the cell line authentication and characterization tests market are adhering to ISO (International Organization of Standardization) standards to boost their credibility credentials. Routine testing of cell cultures is being carried out to prevent misidentification, cross contamination, and genetic drift. Cell authentication is also now required by the National Institutes of Health for grant funding and by a number of scientific journals.
Analysts’ Viewpoint
Cell lines for vaccine development and immortalized lung cell lines are being offered for research studies being conducted during the ongoing COVID-19 pandemic. Stakeholders are complying with cell authentication guidelines to boost credibility. Companies are increasing efforts to simplify human cell STR profiling. Expert analysis and easy-to-understand STR allele table is being preferred by researchers & scientists.
Due to the problem of cell line misidentification, companies in the cell line authentication and characterization tests market should offer standardized methods to ensure cell line identity and quality. Companies should increase efforts to provide authentication testing services designed to ensure consistency and reliability of research data.
Cell Line Authentication and Characterization Tests Market: Overview
This report analyzes the current scenario and future prospects of the global cell line authentication and characterization tests market. Cell line authentication and characterization test is a combination of processes designed to verify the identity of strains and to check that it is free from microbial and other cell line contaminants. It is a type of biological safety testing. Cell line authentication is an important step to ensure the reproducibility and integrity of biomedical research. The contaminants in cell cultures are bacteria, viruses, fungi, and contamination from other cell lines of different or same species. Contaminants alter the physiology and properties of cells, compromising the results of experiments. Increase in the geriatric population and surge in incidence of chronic diseases are projected to drive the global cell line authentication and characterization tests market. Additionally, rise in need of accurate qualitative and quantitative analysis of cell line is anticipated to propel the market during the forecast period from 2021 to 2031.
The report includes an elaborate executive summary, which provides a snapshot of various segments of the global cell line authentication and characterization tests market. It also provides information and data analysis of the global cell line authentication and characterization tests market about segments based on test type, application, end-user, and region.
The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the global cell line authentication and characterization tests market
The report includes company profiles, which provide information about their business, product portfolios, strategic overview, and competition landscape in the global cell line authentication and characterization tests market
The report on the global cell line authentication and characterization tests market offers market attractiveness analysis of regions and segments
The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the global cell line authentication and characterization tests market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global cell line authentication and characterization tests market.
Cell Line Authentication and Characterization Tests Market: Key Segments
In terms of test type, the short tandem repeat (STR) analysis segment dominated the global cell line authentication and characterization tests market in 2020, and the trend is projected to continue during the forecast period
Based on application, the microbial contamination segment held major share of the global cell line authentication and characterization tests market in 2020
In terms of end-user, the pharmaceutical & biotechnology companies segment dominated the global cell line authentication and characterization tests market during the forecast period
Market size and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segment has also been provided from 2021 to 2031, considering 2020 as the base year, and 2017, 2018, and 2019 as historical years.
Cell Line Authentication and Characterization Tests Market: Regional Outlook
The global cell line authentication and characterization tests market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
The global cell line authentication and characterization tests market report provides size and forecast for each region and country/sub-region from 2017 to 2031. The CAGR for each of these regions and countries has also been provided for the forecast period from 2021 to 2031. The cell line authentication and characterization tests market study covers the competitive scenario in these regions.
Companies Covered in Cell Line Authentication and Characterization Tests Market Report
Key players in the global cell line authentication and characterization tests market have been profiled based on attributes such as company overview, product portfolio, financial overview, strategic overview, recent developments, and competitive business strategies
Major companies profiled in the global cell line authentication and characterization tests market report are
- Bio-Synthesis, Inc.
- Cell Line Genetics, Inc.
- Charles River Laboratories
- DNA Forensics Lab India
- Eurofins Genomics (Eurofins Scientific)
- GenomeScan
- IDEXX Laboratories, Inc.
- Laboratory Corporation of America Holdings
- Microsynth AG
- NorthGene Limited (Biofortuna Limited)
- Perfectus Biomed Limited
- Promega Corporation
- SGS SA
- Sigma-Aldrich Co. LLC. (Merck KGaA)
- Thermo Fisher Scientific, Inc.
Key Questions Answered in Cell Line Authentication and Characterization Tests Market Report
- What are the major drivers, restraints, and opportunities in the market?
- What are the revenue share projections of key segments of the global cell line authentication and characterization tests market during the forecast period?
- Which segment is likely to lead the global cell line authentication and characterization tests market in terms of revenue by 2031?
- How technological developments are widening the scope for the global cell line authentication and characterization tests market?
- What is the market position of different companies operating in the global cell line authentication and characterization tests market?
Cell Line Authentication and Characterization Tests Market – Segmentation
Test Type
- Karyotype
- Short Tandem Repeat (STR) Analysis
- Single Nucleotide Polymorphism (SNP) Analysis
- Others
Application
- Microbial Contamination
- Cell Line Identity
- Genetic Stability
- Virus Testing
- Others
End-user
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/111500/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/